← All companies

OACC

Oaktree Acquisition Corp. III Life Sciences

OACC Nasdaq Blank Checks EDGAR ↗

$10.74

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

—

Revenue (TTM)

—

Net income (TTM)

$7.02M

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$1.28M

Total assets

$205M

Gross margin

—

52-week range

$10.30 – $10.88

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-03-31 May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Director or officer change Oct 29, 2025 8-K Director or officer change Oct 17, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Director or officer change Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Director or officer change Jan 7, 2025 8-K Other events Dec 11, 2024 8-K Unregistered sale of equity; Other events Nov 5, 2024 8-K Other events Oct 31, 2024 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Oct 25, 2024

Other filings

SCHEDULE 13G May 15, 2026 SCHEDULE 13G May 11, 2026 SCHEDULE 13G/A Feb 11, 2026 3 Oct 29, 2025 3 Oct 22, 2025 SCHEDULE 13G/A Aug 12, 2025 SCHEDULE 13G/A Jul 15, 2025 3 Jun 16, 2025 SCHEDULE 13G/A May 14, 2025 SCHEDULE 13G/A May 14, 2025 SCHEDULE 13G May 13, 2025 SCHEDULE 13G May 9, 2025 SCHEDULE 13G Feb 14, 2025 SCHEDULE 13G Feb 12, 2025 SC 13G AQR CAPITAL MANAGEMENT LLC Nov 7, 2024 4 Oct 31, 2024 SC 13G Oct 30, 2024 424B4 Oct 24, 2024 CERT Oct 24, 2024 EFFECT Item S-1; Item 2024-10-23; Item 16:30:00 Oct 23, 2024 3 Oct 23, 2024 3 Oct 23, 2024 3 Oct 23, 2024 3 Oct 23, 2024 3 Oct 23, 2024 3 Oct 23, 2024